Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 28 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Zebekakis, Pantelis E [Clear All Filters]
(2020).
Accuracy of a Newly-Introduced Oscillometric Device for the Estimation of Arterial Stiffness Indices in Patients on Peritoneal Dialysis: A Preliminary Validation Study..
Adv Perit Dial. 34(2018), 24-31.
(2018). Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab..
Case Rep Nephrol. 2019, 3614980.
(2019). Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials..
Hypertens Res. 41(5), 309-319.
(2018). Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile..
Med Sci Monit. 16(6), CR307-312.
(2010). Blood pressure and target-organ damage in hemodialysis: but which blood pressure?.
J Hypertens. 35(12), 2552-2553.
(2017). Blood pressure targets in patients with chronic kidney disease: A critical evaluation of clinical-trial evidence and guideline recommendations..
J Clin Hypertens (Greenwich). 22(5), 924-928.
(2020). Clinic and Home Blood Pressure Monitoring for the Detection of Ambulatory Hypertension Among Patients on Peritoneal Dialysis..
Hypertension. 74(4), 998-1004.
(2019). Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population..
Semin Nephrol. 34(5), 483-91.
(2014). Eating during the Hemodialysis Session: A Practice Improving Nutritional Status or a Risk Factor for Intradialytic Hypotension and Reduced Dialysis Adequacy?.
Nutrients. 12(6),
(2020). Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia..
Am J Hypertens. 26(5), 608-16.
(2013). Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients..
Am J Nephrol. 40(3), 242-50.
(2014). Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease..
Int Urol Nephrol. 49(12), 2217-2221.
(2017). Exploring the association of arterial stiffness with estimated glomerular filtration rate: another chicken-egg paradigm?.
J Hypertens. 35(3), 650-651.
(2017). Familial burden of hypertension and its effect on blood pressure levels, insulin resistance, and intracellular ions in Greek offspring..
J Am Soc Hypertens. 3(2), 141-9.
(2009). Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures..
Blood Purif. 37(1), 18-26.
(2014). Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis..
Int Urol Nephrol. 48(4), 601-8.
(2016). Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed..
J Am Soc Hypertens. 12(4), 242-247.
(2018). Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report..
BMC Nephrol. 19(1), 293.
(2018). Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions..
J Clin Hypertens (Greenwich). 21(2), 249-251.
(2019). Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues..
J Clin Hypertens (Greenwich). 18(3), 197-9.
(2016). Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses..
J Clin Hypertens (Greenwich). 21(7), 919-921.
(2019). Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension..
Am J Hypertens. 22(10), 1070-5.
(2009). Prevalence and control of hypertension among patients on haemodialysis..
Eur J Clin Invest. 50(10), e13292.
(2020). Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis..
Am J Hypertens. 35(11), 918-922.
(2022).